Neogen Chemicals Limited received a show cause cum demand notice on September 5, 2026, from the CGST Commissionerate, Belapur. The notice levies a consolidated tax demand of ₹6.97 crore for the financial year 2022-23.

The adjudicating authority issued the notice under section 73 of the CGST Act, 2017, citing discrepancies in input tax credit (ITC) claims and return filings. The company disclosed the development to stock exchanges on September 6, 2026, under Regulation 30 of the SEBI Listing Regulations.

Notice Details

The demand comprises principal tax, interest, and penalty. The source notes that the principal tax amount of ₹1.39 crore was paid via DRC-03 on December 28, 2022, and has been appropriated towards the liability. The current demand primarily covers interest under section 50(1) and penalty under section 73.

Alleged Violations

The notice identifies three specific grounds for the demand:

• Mismatch between GSTR-1 and GSTR-3B returns, where tax was paid via DRC-03 without applicable interest.
• Excess ITC claimed on import of goods due to mismatches between GSTR-3B and GSTR-2B, with no valid Bills of Entry (BOEs) for FY22-23.
• Excess ITC claimed based on unsubstantiated SEZ or import claims, showing a mismatch between GSTR-3B and GSTR-2A.

What the Numbers Show

The composition of the demand highlights a significant penalty component. With the principal tax of approximately ₹1.39 crore already paid, the remaining balance of roughly ₹5.58 crore represents interest and penalties. This structure indicates that the core dispute lies in the procedural compliance of ITC claims rather than the primary tax liability itself, which had been settled earlier.

Company Response

Neogen Chemicals stated it is evaluating the notice and will file a detailed reply within prescribed timelines. The company affirmed that there is no material impact on its financial or operational activities, excluding the specific amount mentioned in the notice. It intends to pursue all available legal remedies.

Neogen Chemicals Limited has approved a ₹245 crore business transfer agreement to consolidate its electrolyte salt manufacturing operations. The move aims to enhance the group’s battery materials strategy by centralizing specialized capabilities within its step-down subsidiary, Neogen Morita New Materials Limited (NML).

The transaction involves the sale of an undertaking by wholly owned subsidiary Neogen Ionics Limited (NIL) to NML. The Board of Directors of both entities approved the Business Transfer Agreement (BTA) on August 31, 2026. Shareholders of NIL also granted necessary approvals during a meeting held on the same date. The transfer is structured on a going concern basis, subject to regulatory approvals and completion of condition precedents outlined in the agreement.

Transaction Structure and Timeline

The BTA mandates that the undertaking be transferred from NIL to NML by March 31, 2027. The consideration of ₹245 crore represents the net value of assets after deducting relevant liabilities. As this is a transaction between wholly owned subsidiaries, it qualifies as a related party transaction but is exempt from specific approval requirements under Regulation 23 of the SEBI Listing Regulations and Section 188 of the Companies Act, 2013.

Financial Impact and Rationale

The strategic move aims to consolidate Neogen’s Electrolyte Salt (LiPF6) businesses under NML. NIL, incorporated in March 2023, reported a turnover of ₹35.97 crore for the fiscal year ended March 31, 2026. In contrast, NML, incorporated in July 2025, reported nil turnover for the same period.

Despite contributing zero percent to the consolidated revenue of the parent company in FY26, the undertaking being transferred holds significant balance sheet weight. Its net worth stood at ₹155.52 crore as of March 31, 2026, representing 19.05% of Neogen Chemicals’ consolidated net worth and 57.36% of NIL’s consolidated net worth.

What the Numbers Show

The divergence between NIL’s revenue contribution and its net worth contribution highlights the capital-intensive nature of the electrolyte salt assets. While the unit generated no consolidated revenue impact in FY26, it commands nearly one-fifth of the group’s total net worth. This suggests the transferred assets are primarily fixed or inventory-based investments rather than high-turnover trading books, aligning with the strategic goal of centralizing specialized manufacturing capabilities within NML.